| Product Name | J9 | 
| Description | Glucocorticoid resistance inhibitor | 
| Purity | 99.90% | 
| Molecular Formula | C12H12N4 | 
| Molecular Weight | 212.26 | 
| Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. | 
| Storage Temperature | -20ºC | 
| Shipping Temperature | Blue Ice or 4ºC | 
| Product Type | Inhibitor | 
| Solubility | Soluble in CDCI3 | 
| Source | Synthetic | 
| Appearance | White Solid | 
| SMILES | NC1=NC(C2CC2)=C(C3=CC=NC=C3)C=N1 | 
| InChI | InChI=1S/C12H12N4/c13-12-15-7-10(8-3-5-14-6-4-8)11(16-12)9-1-2-9/h3-7,9H,1-2H2,(H2,13,15,16) | 
| InChIKey | PQLYPFZAOUDDHB-UHFFFAOYSA-N | 
| Safety Phrases | Classification: Caution: Substance not yet fully tested. Safety Phrases: S22 - Do not breathe dust S24/25 - Avoid contact with skin and eyes S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection | 
| Cite This Product | J9 (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-182) | 
| Alternative Names | 4-cyclopropyl-5-(pyridin-4-yl)pyrimidin-2-amine | 
| Research Areas | Cancer, Cell Signaling | 
| PubChem ID | PMC4094258 | 
| Scientific Background | J9 is a small molecule that enhances glucocorticoid receptor expression, thereby sensitizing T-cell acute lymphoblastic leukemia (T-ALL) cells to dexamethasone. While primarily studied in oncology, its mechanism of modulating steroid receptor pathways may have implications in neuroinflammation and stress-related neural disorders. Glucocorticoid signaling plays a role in brain function and resilience to stress, suggesting that J9 could be explored for its potential to modulate neuroendocrine responses in psychiatric and neurodegenerative conditions. | 
| References | 1. Cantley A.M., et al. (2014) ACS Medicinal Chemistry Letters 5.7: 754-759. | 
Reviews
There are no reviews yet.